Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMG-guided vs Palpation-guided Botulinum Toxin A for Glabellar Lines
NCT05517538Completed
- Start
- Aug 2021
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A in glabellar rhytides (2 arms). Primary endpoints: Interference pattern Envelope amplitude at 3 months and Muscle activity percentage at 3 months. Started Aug 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar rhytides
Beyond the preview
Go deeper on NCT05517538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05517538.